PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,539,852 | -1.6% | 2,042,321 | +0.4% | 0.00% | – |
| Q2 2023 | $12,739,306 | +36.0% | 2,035,033 | +3.6% | 0.00% | – |
| Q1 2023 | $9,365,513 | -60.9% | 1,963,420 | -28.7% | 0.00% | -100.0% |
| Q4 2022 | $23,956,373 | -41.4% | 2,753,606 | -19.8% | 0.00% | 0.0% |
| Q3 2022 | $40,865,000 | -14.5% | 3,433,965 | +2.3% | 0.00% | 0.0% |
| Q2 2022 | $47,823,000 | -16.1% | 3,355,964 | +22.5% | 0.00% | 0.0% |
| Q1 2022 | $57,023,000 | -6.8% | 2,738,883 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $61,167,000 | -22.6% | 2,647,946 | -0.2% | 0.00% | -50.0% |
| Q3 2021 | $79,071,000 | +3.3% | 2,653,394 | +18.4% | 0.00% | 0.0% |
| Q2 2021 | $76,576,000 | +96.1% | 2,241,711 | +88.8% | 0.00% | +100.0% |
| Q1 2021 | $39,050,000 | -45.2% | 1,187,278 | +2.5% | 0.00% | -50.0% |
| Q4 2020 | $71,260,000 | +9936.6% | 1,158,507 | +5692.5% | 0.00% | – |
| Q3 2020 | $710,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |